Prevention of hiv-infection with tmc278

Details Prevention of hiv-infection with tmc278 Prevention of hiv-infection with tmc278

A - Human Necessities

61

K

A61K 31/505 (2006.01) A61P 31/18 (2006.01)

Patent

CA 2602231

This invention relates to the use of a parenteral formulation comprising the NNRTI TMC278 for the long term prevention of HIV infection in a subject at risk of being infected by HIV, which comprises the intermittent administration of the said formulation at long time intervals.

La présente invention a trait à l'utilisation d'une formulation parentérale comportant l'inhibiteur de la transcriptase inverse nucléosidique TMC278 pour la prévention à long terme d'infection par le VIH chez un sujet à risque d'une infection par le VIH, comprenant l'administration intermittente de ladite formulation à de longs intervalles de temps.

Affiliated with

Also associated with

Rating

Prevention of hiv-infection with tmc278 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prevention of hiv-infection with tmc278, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prevention of hiv-infection with tmc278 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1594967